A Clinical Trial of Cidabenamine Plus Azacitidine to Prevent Post-Transplant Progression in High-Risk Peripheral T-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Peripheral T Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai General hospital,Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Xianmin Song, MD) · shongxm@139.com · +862163240090

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Relapsed/Refractory Peripheral T Cell Lymphoma

Abroad (travel likely)RecruitingPHASE3

Beijing, China

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Indolent Lymphomas · Lymphoma · Chronic Lymphocytic Leukemia

Abroad (travel likely)Recruiting

Chapel Hill, United States

Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma

T Cell Lymphoma · T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

New Haven, United States · New York, United States

T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-CR

Peripheral T Cell Lymphoma

Abroad (travel likely)Recruiting

Shanghai, China